Registry rank 62 · Portfolio as of 2026-02-28

AMCAP Fund

AMCFX · AMCPX · AMPCX · AMPFX · CAFAX · CAFCX · CAFEX · CAFFX · FMACX · FMCMX · FMMMX · RAEBX · RAEFX · RAFAX · RAFBX · RAFCX · RAFEX · RAFFX · RAFGX · TACMX · TAMCX

Best-fit active share48.3%vs IWF · fund as of 2026-02-28 · proxy as of 2026-03-31
Declared-benchmark active shareNot filed yetNo mapped declared benchmark
AMCFX expense ratio0.44%SEC expense filing · as of 2026-04-30
AMCFX fee per active unit0.91%expense as of 2026-04-30; fund as of 2026-02-28; proxy as of 2026-03-31

Filed fees in dollars

Assumptions for each dollar figure: $100,000 starting amount · 5.0% annual return · annual compounding · fees deducted annually · 0.00% computed index-control baseline. Methodology.

Illustrated difference between each class’s filed expense ratio and the computed index-control baseline.
Share class and filing10 years20 years30 years
AMCFX0.44% · SEC expense filing · as of 2026-04-30$6,699$21,374$51,157
AMCPX0.64% · SEC expense filing · as of 2026-04-30$9,661$30,539$72,427
AMPCX1.40% · SEC expense filing · as of 2026-04-30$20,461$62,470$143,264
AMPFX0.71% · SEC expense filing · as of 2026-04-30$10,685$33,669$79,596
CAFAX0.68% · SEC expense filing · as of 2026-04-30$10,247$32,332$76,541
CAFCX1.45% · SEC expense filing · as of 2026-04-30$21,147$64,420$147,418
CAFEX0.92% · SEC expense filing · as of 2026-04-30$13,722$42,822$100,286
CAFFX0.75% · SEC expense filing · as of 2026-04-30$11,268$35,439$83,631
FMACX0.33% · SEC expense filing · as of 2026-04-30$5,048$16,189$38,946
FMCMX0.38% · SEC expense filing · as of 2026-04-30$5,800$18,559$44,543
FMMMX0.43% · SEC expense filing · as of 2026-04-30$6,549$20,907$50,062
RAEBX1.14% · SEC expense filing · as of 2026-04-30$16,846$52,042$120,700
RAEFX0.48% · SEC expense filing · as of 2026-04-30$7,295$23,234$55,506
RAFAX1.42% · SEC expense filing · as of 2026-04-30$20,735$63,252$144,933
RAFBX1.43% · SEC expense filing · as of 2026-04-30$20,873$63,642$145,764
RAFCX0.98% · SEC expense filing · as of 2026-04-30$14,580$45,373$105,978
RAFEX0.68% · SEC expense filing · as of 2026-04-30$10,247$32,332$76,541
RAFFX0.38% · SEC expense filing · as of 2026-04-30$5,800$18,559$44,543
RAFGX0.33% · SEC expense filing · as of 2026-04-30$5,048$16,189$38,946
TACMX0.70% · SEC expense filing · as of 2026-04-30$10,539$33,224$78,580
TAMCX0.65% · SEC expense filing · as of 2026-04-30$9,807$30,988$73,459

These figures are illustrations, not predictions or personalized advice. Returns and fees can differ. Read the research disclaimer.

Change the illustration

Assumptions for the dollar figures below: $100,000 starting amount; 5.0% annual return; 20 years; annual compounding; fees deducted annually; 0.00% computed index-control baseline. AMCFX SEC expense filing, as of 2026-04-30. Methodology.

Illustration for AMCFX; expense ratio filed as of 2026-04-30.
ResultAmount
Ending value at baseline$265,330
Ending value at filed expense ratio$243,956
Difference attributed to fee drag$21,374

This is an illustration, not a prediction or personalized advice. Returns and fees can differ. Read the research disclaimer.

Largest active differences vs IWF

The bars are labeled and repeated in the table; color is not the only signal. Linked company names open Buy Like Buffett’s company record; Sensible Investor does not score stocks.

ELI LILLY AND COMPANY+2.23%
VERTEX PHARMACEUTICALS INCORPORATED+2.14%
HoldingFundIWFDifference
APPLE INC.2.62%11.66%-9.04%
NVIDIA CORPORATION6.37%12.95%-6.58%
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD3.07%0.00%+3.07%
MICROSOFT CORPORATION5.80%8.84%-3.04%
TESLA, INC.0.71%3.55%-2.84%
TRANSDIGM GROUP INCORPORATED2.55%0.04%+2.51%
ELI LILLY AND COMPANY4.89%2.66%+2.23%
VERTEX PHARMACEUTICALS INCORPORATED2.55%0.41%+2.14%
Viking Holdings Ltd1.55%0.05%+1.51%
MERCADOLIBRE INC1.50%0.00%+1.50%

Source and verification

SEC N-PORT filing · filed 2026-04-27 · period 2026-02-28

SEC expense filing · period 2026-04-30

Immutable verification record · Active-share method